Michael Fonstein

All filings by Michael Fonstein on record concern Cytocom, Inc. We count 64 filings; the first trade dates from 24 August 2009 and the latest from 26 June 2012.

In open-market terms, that means 1 purchase worth €3,502 on one side and 62 sales worth €355k on the other. On balance, insiders were net sellers of €352k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. In 2012 alone, the filings show no purchases and 3 sales.

The record was last updated on 28 June 2012 with a share grant in Cytocom, Inc. The clock since the last published purchase (7 September 2011) now reads 5,541 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.